| NAME |
NAPROXEN 125MG/5ML SUSP,ORAL |
| VA GENERIC NAME |
NAPROXEN |
| DOSAGE FORM |
SUSP |
| FDA MED GUIDE |
NSAIDs_(Class)_(2022).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
125 |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| UNITS |
MG/5ML |
| DSS NUMBER |
6 |
| NATIONAL FORMULARY NAME |
NAPROXEN SUSP |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
NAPROXEN 125MG/5ML SUSP |
| VA PRODUCT IDENTIFIER |
N0010 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
ML |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4006834 |
| EFFECTIVE DATE/TIME |
-
- 2005-03-10 00:00:00
- STATUS: ACTIVE
|
